Early Ezetimibe Initiation After Myocardial Infarction Protects Against Later Cardiovascular Outcomes in the SWEDEHEART Registry
MI care pathways should implement early combination therapy with statins and ezetimibe as standard care, because delaying use of combination LLT or using high-intensity statin monotherapy is associated with avoidable harm.
Authors
- Kausik Kumar Ray (ORCID: https://orcid.org/0000-0003-0508-0954)
- Stefan Gustafsson (ORCID: https://orcid.org/0000-0001-5894-0351)
- Emil Hagström (ORCID: https://orcid.org/0000-0003-3221-0144)
- Margrét Leósdóttir (ORCID: https://orcid.org/0000-0003-1677-1566)
- Tomas Jernberg (ORCID: https://orcid.org/0000-0003-1695-379X)
- Jessica R. Schubert (ORCID: https://orcid.org/0000-0002-1917-5885)
- Julia Brandts (ORCID: https://orcid.org/0000-0002-1141-1126)
- Thomas Cars (ORCID: https://orcid.org/0009-0008-0912-8226)
- Johan Sundström (ORCID: https://orcid.org/0000-0003-2247-8454)
Institutions
- Uppsala University (SE)
- Uppsala University Hospital (SE)
- Malmö University (SE)
- Karolinska Institutet (SE)
- NIHR Imperial Biomedical Research Centre (GB)
- Skåne University Hospital (SE)
- Imperial College London (GB)
Publication Details
- Journal
- Journal of the American College of Cardiology
- Published
- 2025-04-01
- DOI
- https://doi.org/10.1016/j.jacc.2025.02.007
- Citations
- 39
- Primary Topic
- Lipoproteins and Cardiovascular Health
- Type
- article
- Field-Weighted Citation Impact
- 78.25
Funders
- Riksförbundet HjärtLung
- Lunds Universitet
- Uppsala Universitet
- Region Skåne
- Region Uppsala
- NIHR Imperial Biomedical Research Centre